Cargando…
Effect of Structured Phenolic Lipids with EPA/DHA and Gallic Acid against Metabolic-Associated Fatty Liver Disease (MAFLD) in Mice
Obesity is the leading risk factor for developing metabolic (dysfunction)-associated fatty liver disease (MAFLD). The food industry has an essential role in searching for new strategies to improve primary food sources to revert some of the metabolic alterations induced by obesity. There is consisten...
Autores principales: | Dovale-Rosabal, Gretel, Espinosa, Alejandra, Rodríguez, Alicia, Barriga, Andrés, Palomino-Calderón, Alan, Romero, Nalda, Troncoso, Rodrigo Hernán, Aubourg, Santiago Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696657/ https://www.ncbi.nlm.nih.gov/pubmed/36431812 http://dx.doi.org/10.3390/molecules27227702 |
Ejemplares similares
-
Synthesis of EPA- and DHA-Enriched Structured Acylglycerols at the sn-2 Position Starting from Commercial Salmon Oil by Enzymatic Lipase Catalysis under Supercritical Conditions
por: Dovale-Rosabal, Gretel, et al.
Publicado: (2021) -
EPA/DHA Concentrate by Urea Complexation Decreases Hyperinsulinemia and Increases Plin5 in the Liver of Mice Fed a High-Fat Diet
por: Espinosa, Alejandra, et al.
Publicado: (2020) -
Concentration of EPA and DHA from Refined Salmon Oil by Optimizing the Urea–Fatty Acid Adduction Reaction Conditions Using Response Surface Methodology
por: Dovale-Rosabal, Gretel, et al.
Publicado: (2019) -
Marine Cryptophytes Are Great Sources of EPA and DHA
por: Peltomaa, Elina, et al.
Publicado: (2017) -
Are EPA and DHA Derivatives Involved in IBD Remission?
por: Kikut, Justyna, et al.
Publicado: (2022)